BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24773246)

  • 1. Genetic profiling by single-nucleotide polymorphism-based array analysis defines three distinct subtypes of orbital meningioma.
    Ho CY; Mosier S; Safneck J; Salomao DR; Miller NR; Eberhart CG; Gocke CD; Batista DA; Rodriguez FJ
    Brain Pathol; 2015 Mar; 25(2):193-201. PubMed ID: 24773246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic significance of genetic regional heterogeneity in meningiomas.
    Pfisterer WK; Hank NC; Preul MC; Hendricks WP; Pueschel J; Coons SW; Scheck AC
    Neuro Oncol; 2004 Oct; 6(4):290-9. PubMed ID: 15494096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
    Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.
    Mocker K; Holland H; Ahnert P; Schober R; Bauer M; Kirsten H; Koschny R; Meixensberger J; Krupp W
    Pathol Res Pract; 2011 Jan; 207(1):67-72. PubMed ID: 20926204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1p and 3p deletions in meningiomas without detectable aberrations of chromosome 22 identified by comparative genomic hybridization.
    Carlson KM; Bruder C; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1997 Dec; 20(4):419-24. PubMed ID: 9408760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of loss of 1p and alterations of chromosome 14 in meningioma progression.
    Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Callaghan R; Collado M; Roldan P; Llombart-Bosch A
    Cancer Genet Cytogenet; 2004 Jan; 148(2):123-8. PubMed ID: 14734222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
    Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
    Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
    Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
    BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between mutation of the NF2 gene and monosomy 22 in menopausal women with sporadic meningiomas.
    Tabernero M; Jara-Acevedo M; Nieto AB; Caballero AR; Otero A; Sousa P; Gonçalves J; Domingues PH; Orfao A
    BMC Med Genet; 2013 Oct; 14():114. PubMed ID: 24171707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.
    Pérez-Magán E; Rodríguez de Lope A; Ribalta T; Ruano Y; Campos-Martín Y; Pérez-Bautista G; García JF; García-Claver A; Fiaño C; Hernández-Moneo JL; Mollejo M; Meléndez B
    Neuro Oncol; 2010 Dec; 12(12):1278-90. PubMed ID: 20685720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation of commonly deleted chromosomal regions in meningiomas by high-density single nucleotide polymorphism genotyping arrays.
    Tabernero MD; Maíllo A; Nieto AB; Diez-Tascón C; Lara M; Sousa P; Otero A; Castrillo A; Patino-Alonso Mdel C; Espinosa A; Mackintosh C; de Alava E; Orfao A
    Genes Chromosomes Cancer; 2012 Jun; 51(6):606-17. PubMed ID: 22371336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of 1p/19q codeletion on the diagnosis and prognosis of different grades of meningioma.
    Basaran R; Uslu S; Gucluer B; Onoz M; Isik N; Tiryaki M; Yakicier C; Sav A; Elmaci I
    Br J Neurosurg; 2016 Oct; 30(5):571-6. PubMed ID: 27173440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic deletions at 1p and 14q are associated with an abnormal cDNA microarray gene expression pattern in meningiomas but not in schwannomas.
    Martínez-Glez V; Alvarez L; Franco-Hernández C; Torres-Martin M; de Campos JM; Isla A; Vaquero J; Lassaletta L; Castresana JS; Casartelli C; Rey JA
    Cancer Genet Cytogenet; 2010 Jan; 196(1):1-6. PubMed ID: 19963129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 1p36 and 22qter deletions in paraffin block sections of intracranial meningiomas.
    Yilmaz Z; Sahin FI; Atalay B; Ozen O; Caner H; Bavbek M; Demirhan B; Altinörs N
    Pathol Oncol Res; 2005; 11(4):224-8. PubMed ID: 16388319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region.
    Wozniak K; Piaskowski S; Gresner SM; Golanska E; Bieniek E; Bigoszewska K; Sikorska B; Szybka M; Kulczycka-Wojdala D; Zakrzewska M; Zawlik I; Papierz W; Stawski R; Jaskolski DJ; Och W; Sieruta M; Liberski PP; Rieske P
    Cancer Genet Cytogenet; 2008 May; 183(1):14-20. PubMed ID: 18474292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity analysis of benign, atypical, and anaplastic meningiomas.
    Lee JY; Finkelstein S; Hamilton RL; Rekha R; King JT; Omalu B
    Neurosurgery; 2004 Nov; 55(5):1163-73. PubMed ID: 15509323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.